

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative T cell selection (GO:0043383) | 8.62218987 |
| 2 | negative thymic T cell selection (GO:0045060) | 8.44253030 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 8.12221579 |
| 4 | positive thymic T cell selection (GO:0045059) | 7.63014794 |
| 5 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 7.26595652 |
| 6 | positive T cell selection (GO:0043368) | 7.11344870 |
| 7 | thymic T cell selection (GO:0045061) | 7.09716401 |
| 8 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.97917198 |
| 9 | regulation of isotype switching to IgG isotypes (GO:0048302) | 6.96663473 |
| 10 | response to interleukin-15 (GO:0070672) | 6.87327651 |
| 11 | negative regulation of cell killing (GO:0031342) | 6.83225730 |
| 12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.83225730 |
| 13 | T cell selection (GO:0045058) | 6.62634790 |
| 14 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.38429547 |
| 15 | cellular response to interleukin-15 (GO:0071350) | 6.34335320 |
| 16 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.28246291 |
| 17 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.28246291 |
| 18 | regulation of gamma-delta T cell activation (GO:0046643) | 6.27257221 |
| 19 | interferon-gamma production (GO:0032609) | 5.87878578 |
| 20 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 5.81227603 |
| 21 | regulation of T cell tolerance induction (GO:0002664) | 5.68028957 |
| 22 | leukocyte aggregation (GO:0070486) | 5.47157541 |
| 23 | T cell receptor signaling pathway (GO:0050852) | 5.45303486 |
| 24 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.36224544 |
| 25 | T cell costimulation (GO:0031295) | 5.31780373 |
| 26 | tolerance induction (GO:0002507) | 5.27097335 |
| 27 | lymphocyte costimulation (GO:0031294) | 5.24371353 |
| 28 | T cell migration (GO:0072678) | 5.19858636 |
| 29 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.82520894 |
| 30 | positive regulation of interleukin-2 production (GO:0032743) | 4.73064016 |
| 31 | activated T cell proliferation (GO:0050798) | 4.72984367 |
| 32 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.63573465 |
| 33 | positive regulation of tolerance induction (GO:0002645) | 4.62816650 |
| 34 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.62000389 |
| 35 | regulation of regulatory T cell differentiation (GO:0045589) | 4.53869875 |
| 36 | positive regulation of granulocyte differentiation (GO:0030854) | 4.53518808 |
| 37 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.42451427 |
| 38 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.33895399 |
| 39 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.30117284 |
| 40 | positive regulation of isotype switching (GO:0045830) | 4.28965867 |
| 41 | positive regulation of humoral immune response (GO:0002922) | 4.18808130 |
| 42 | regulation of isotype switching (GO:0045191) | 4.16221065 |
| 43 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.14204608 |
| 44 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.14204608 |
| 45 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.11740367 |
| 46 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.11032612 |
| 47 | regulation of tolerance induction (GO:0002643) | 4.03231702 |
| 48 | negative regulation of T cell mediated immunity (GO:0002710) | 4.03044465 |
| 49 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.00887237 |
| 50 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.00887237 |
| 51 | positive regulation of B cell mediated immunity (GO:0002714) | 3.81373597 |
| 52 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.81373597 |
| 53 | regulation of interleukin-2 production (GO:0032663) | 3.80045164 |
| 54 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.76870045 |
| 55 | positive regulation of DNA recombination (GO:0045911) | 3.68014812 |
| 56 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.65172825 |
| 57 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.64942805 |
| 58 | regulation of B cell mediated immunity (GO:0002712) | 3.63475212 |
| 59 | regulation of response to interferon-gamma (GO:0060330) | 3.62572136 |
| 60 | regulation of immunoglobulin production (GO:0002637) | 3.62255208 |
| 61 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.62028209 |
| 62 | T cell differentiation (GO:0030217) | 3.61318900 |
| 63 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.59798916 |
| 64 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.55378271 |
| 65 | NIK/NF-kappaB signaling (GO:0038061) | 3.52775692 |
| 66 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.52037781 |
| 67 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.51918657 |
| 68 | regulation of defense response to virus by virus (GO:0050690) | 3.51268334 |
| 69 | positive regulation of immunoglobulin production (GO:0002639) | 3.49295985 |
| 70 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.47142849 |
| 71 | alpha-beta T cell differentiation (GO:0046632) | 3.46770556 |
| 72 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.46487869 |
| 73 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.43961271 |
| 74 | alpha-beta T cell activation (GO:0046631) | 3.43910779 |
| 75 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.42500829 |
| 76 | mast cell activation (GO:0045576) | 3.41847778 |
| 77 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.41042582 |
| 78 | positive regulation of B cell differentiation (GO:0045579) | 3.40276228 |
| 79 | T cell homeostasis (GO:0043029) | 3.39705275 |
| 80 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.38495994 |
| 81 | B cell receptor signaling pathway (GO:0050853) | 3.37259489 |
| 82 | detection of bacterium (GO:0016045) | 3.35953352 |
| 83 | T cell activation (GO:0042110) | 3.32669838 |
| 84 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.29301750 |
| 85 | regulation of granulocyte differentiation (GO:0030852) | 3.28468366 |
| 86 | Peyers patch development (GO:0048541) | 3.27752785 |
| 87 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.27752785 |
| 88 | positive regulation of interleukin-4 production (GO:0032753) | 3.26930555 |
| 89 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.23962953 |
| 90 | detection of other organism (GO:0098543) | 3.23321763 |
| 91 | regulation of interleukin-4 production (GO:0032673) | 3.21196253 |
| 92 | positive regulation of T cell activation (GO:0050870) | 3.20396756 |
| 93 | leukocyte cell-cell adhesion (GO:0007159) | 3.20193469 |
| 94 | natural killer cell differentiation (GO:0001779) | 3.19549162 |
| 95 | positive regulation of cell killing (GO:0031343) | 3.19305354 |
| 96 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.19131196 |
| 97 | T-helper cell differentiation (GO:0042093) | 3.19131196 |
| 98 | T cell proliferation (GO:0042098) | 3.19008543 |
| 99 | lymphocyte migration (GO:0072676) | 3.16497274 |
| 100 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.16415504 |
| 101 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.16415504 |
| 102 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.15656843 |
| 103 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.15153265 |
| 104 | cellular response to interleukin-4 (GO:0071353) | 3.14981790 |
| 105 | regulation of cell killing (GO:0031341) | 3.14955408 |
| 106 | lymphocyte homeostasis (GO:0002260) | 3.14604183 |
| 107 | cellular response to type I interferon (GO:0071357) | 3.13433506 |
| 108 | type I interferon signaling pathway (GO:0060337) | 3.13433506 |
| 109 | response to type I interferon (GO:0034340) | 3.12852004 |
| 110 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.12594592 |
| 111 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.12594592 |
| 112 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.12594592 |
| 113 | modulation by symbiont of host immune response (GO:0052553) | 3.12594592 |
| 114 | positive regulation by symbiont of host defense response (GO:0052509) | 3.12594592 |
| 115 | modulation by symbiont of host defense response (GO:0052031) | 3.12594592 |
| 116 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.10768155 |
| 117 | natural killer cell activation (GO:0030101) | 3.10077646 |
| 118 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.09507203 |
| 119 | regulation of immunoglobulin secretion (GO:0051023) | 3.09053852 |
| 120 | cellular extravasation (GO:0045123) | 3.08061197 |
| 121 | regulation of lymphocyte mediated immunity (GO:0002706) | 3.07998277 |
| 122 | myeloid dendritic cell differentiation (GO:0043011) | 3.07578301 |
| 123 | regulation of chronic inflammatory response (GO:0002676) | 3.06366424 |
| 124 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 3.06272132 |
| 125 | negative regulation of phagocytosis (GO:0050765) | 3.05964695 |
| 126 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.05327187 |
| 127 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 3.05202674 |
| 128 | sequestering of actin monomers (GO:0042989) | 3.04240354 |
| 129 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.03796062 |
| 130 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.02323842 |
| 131 | regulation of B cell differentiation (GO:0045577) | 3.00934869 |
| 132 | positive regulation of alpha-beta T cell activation (GO:0046635) | 3.00415612 |
| 133 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.00150825 |
| 134 | lymph node development (GO:0048535) | 2.98494475 |
| 135 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.97930325 |
| 136 | regulation of alpha-beta T cell activation (GO:0046634) | 2.97250028 |
| 137 | myeloid dendritic cell activation (GO:0001773) | 2.96864025 |
| 138 | positive regulation of T cell differentiation (GO:0045582) | 2.95397000 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 8.24667040 |
| 2 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.01043458 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 3.90736677 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.79552662 |
| 5 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.77547541 |
| 6 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.61587921 |
| 7 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.61582654 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.60013501 |
| 9 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.40397633 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.38320550 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.30761293 |
| 12 | MYB_26560356_Chip-Seq_TH2_Human | 3.26806999 |
| 13 | MAF_26560356_Chip-Seq_TH1_Human | 3.07565836 |
| 14 | UTX_26944678_Chip-Seq_JUKART_Human | 2.79930412 |
| 15 | MYB_26560356_Chip-Seq_TH1_Human | 2.78378758 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.72862578 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.64228298 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.61513520 |
| 19 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.55618875 |
| 20 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.53717155 |
| 21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.50937395 |
| 22 | MAF_26560356_Chip-Seq_TH2_Human | 2.34482475 |
| 23 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.32604666 |
| 24 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.17261644 |
| 25 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.08081972 |
| 26 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.02335065 |
| 27 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00528197 |
| 28 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.91543367 |
| 29 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.91216497 |
| 30 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.84159826 |
| 31 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.83866336 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.81694708 |
| 33 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.81338384 |
| 34 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.77480664 |
| 35 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.74348449 |
| 36 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.73287514 |
| 37 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.71512987 |
| 38 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.66044749 |
| 39 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.64824855 |
| 40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.64437775 |
| 41 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.59218530 |
| 42 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.57547400 |
| 43 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.55981541 |
| 44 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.55618503 |
| 45 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52129235 |
| 46 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49888475 |
| 47 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.49004683 |
| 48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.46882218 |
| 49 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.44446999 |
| 50 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.41247685 |
| 51 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.37866323 |
| 52 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36317459 |
| 53 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.35925475 |
| 54 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.34735811 |
| 55 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.32815942 |
| 56 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31340597 |
| 57 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.29196177 |
| 58 | SPI1_23127762_ChIP-Seq_K562_Human | 1.28938267 |
| 59 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.26394319 |
| 60 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.25547339 |
| 61 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22737102 |
| 62 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.20600088 |
| 63 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18642119 |
| 64 | GATA3_26560356_Chip-Seq_TH2_Human | 1.14650686 |
| 65 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.14069012 |
| 66 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11231171 |
| 67 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.11053893 |
| 68 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.10812504 |
| 69 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.07621974 |
| 70 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.07402787 |
| 71 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07222914 |
| 72 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.04128450 |
| 73 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.99691388 |
| 74 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97247396 |
| 75 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.95247215 |
| 76 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94245756 |
| 77 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.94154391 |
| 78 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.94050186 |
| 79 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.93529117 |
| 80 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93234304 |
| 81 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.93058837 |
| 82 | GATA1_19941826_ChIP-Seq_K562_Human | 0.92596162 |
| 83 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92592140 |
| 84 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.92526091 |
| 85 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.91845834 |
| 86 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.90326557 |
| 87 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89894653 |
| 88 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.89823548 |
| 89 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.88137413 |
| 90 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.87991727 |
| 91 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86996713 |
| 92 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.86807962 |
| 93 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86807002 |
| 94 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86480187 |
| 95 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.82709332 |
| 96 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.80129701 |
| 97 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.80003296 |
| 98 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79787112 |
| 99 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.79002671 |
| 100 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.78667835 |
| 101 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.78038704 |
| 102 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.77846536 |
| 103 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.77817552 |
| 104 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.77223361 |
| 105 | GATA3_26560356_Chip-Seq_TH1_Human | 0.76667722 |
| 106 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.76403461 |
| 107 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.75470142 |
| 108 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.74591685 |
| 109 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.73728538 |
| 110 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.73633394 |
| 111 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.73252081 |
| 112 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.73129177 |
| 113 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.72523055 |
| 114 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.72042210 |
| 115 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.71264366 |
| 116 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.69997945 |
| 117 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.69385457 |
| 118 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.68178327 |
| 119 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.67787943 |
| 120 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.66879392 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 6.29018779 |
| 2 | MP0005671_abnormal_response_to | 4.42179144 |
| 3 | MP0000685_abnormal_immune_system | 3.81765737 |
| 4 | MP0001800_abnormal_humoral_immune | 3.18244621 |
| 5 | MP0002166_altered_tumor_susceptibility | 3.17536661 |
| 6 | MP0009333_abnormal_splenocyte_physiolog | 3.10134963 |
| 7 | MP0001790_abnormal_immune_system | 3.06798080 |
| 8 | MP0005387_immune_system_phenotype | 3.06798080 |
| 9 | MP0001835_abnormal_antigen_presentation | 3.04983449 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.93558686 |
| 11 | MP0002398_abnormal_bone_marrow | 2.85899921 |
| 12 | MP0003436_decreased_susceptibility_to | 2.84125685 |
| 13 | MP0000703_abnormal_thymus_morphology | 2.80999281 |
| 14 | MP0002420_abnormal_adaptive_immunity | 2.78588929 |
| 15 | MP0002723_abnormal_immune_serum | 2.77296332 |
| 16 | MP0001819_abnormal_immune_cell | 2.73510033 |
| 17 | MP0002405_respiratory_system_inflammati | 2.69677626 |
| 18 | MP0003866_abnormal_defecation | 2.67307495 |
| 19 | MP0001873_stomach_inflammation | 2.60990625 |
| 20 | MP0002006_tumorigenesis | 2.60534486 |
| 21 | MP0002396_abnormal_hematopoietic_system | 2.59351210 |
| 22 | MP0003300_gastrointestinal_ulcer | 2.59339658 |
| 23 | MP0009785_altered_susceptibility_to | 2.56120549 |
| 24 | MP0002933_joint_inflammation | 2.53396290 |
| 25 | MP0002452_abnormal_antigen_presenting | 2.48212618 |
| 26 | MP0000716_abnormal_immune_system | 2.43864931 |
| 27 | MP0006082_CNS_inflammation | 2.40425584 |
| 28 | MP0005025_abnormal_response_to | 2.35973595 |
| 29 | MP0002722_abnormal_immune_system | 2.34634661 |
| 30 | MP0010155_abnormal_intestine_physiology | 2.33142735 |
| 31 | MP0003724_increased_susceptibility_to | 2.25656038 |
| 32 | MP0000689_abnormal_spleen_morphology | 2.25571451 |
| 33 | MP0004947_skin_inflammation | 2.10637920 |
| 34 | MP0002429_abnormal_blood_cell | 1.99136791 |
| 35 | MP0002148_abnormal_hypersensitivity_rea | 1.90283422 |
| 36 | MP0003303_peritoneal_inflammation | 1.87000348 |
| 37 | MP0004510_myositis | 1.73950612 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.64794367 |
| 39 | MP0001853_heart_inflammation | 1.63360949 |
| 40 | MP0002419_abnormal_innate_immunity | 1.61613026 |
| 41 | MP0004381_abnormal_hair_follicle | 1.61201097 |
| 42 | MP0004808_abnormal_hematopoietic_stem | 1.53002542 |
| 43 | MP0005464_abnormal_platelet_physiology | 1.43155081 |
| 44 | MP0002277_abnormal_respiratory_mucosa | 1.39986100 |
| 45 | MP0005310_abnormal_salivary_gland | 1.36559261 |
| 46 | MP0000858_altered_metastatic_potential | 1.31531536 |
| 47 | MP0000465_gastrointestinal_hemorrhage | 1.21157857 |
| 48 | MP0010352_gastrointestinal_tract_polyps | 1.17247125 |
| 49 | MP0001533_abnormal_skeleton_physiology | 1.16807680 |
| 50 | MP0000490_abnormal_crypts_of | 1.15414862 |
| 51 | MP0008057_abnormal_DNA_replication | 1.13665296 |
| 52 | MP0001851_eye_inflammation | 1.11354216 |
| 53 | MP0003448_altered_tumor_morphology | 1.10311107 |
| 54 | MP0005451_abnormal_body_composition | 1.05321893 |
| 55 | MP0008469_abnormal_protein_level | 1.04519539 |
| 56 | MP0002019_abnormal_tumor_incidence | 1.00671957 |
| 57 | MP0003172_abnormal_lysosome_physiology | 0.98283038 |
| 58 | MP0008961_abnormal_basal_metabolism | 0.96629630 |
| 59 | MP0008260_abnormal_autophagy | 0.96052054 |
| 60 | MP0005075_abnormal_melanosome_morpholog | 0.94592766 |
| 61 | MP0004130_abnormal_muscle_cell | 0.91435922 |
| 62 | MP0001545_abnormal_hematopoietic_system | 0.90207298 |
| 63 | MP0005397_hematopoietic_system_phenotyp | 0.90207298 |
| 64 | MP0002254_reproductive_system_inflammat | 0.89161006 |
| 65 | MP0005023_abnormal_wound_healing | 0.84153195 |
| 66 | MP0002009_preneoplasia | 0.84110030 |
| 67 | MP0003191_abnormal_cellular_cholesterol | 0.84091478 |
| 68 | MP0005076_abnormal_cell_differentiation | 0.84076895 |
| 69 | MP0003077_abnormal_cell_cycle | 0.83739510 |
| 70 | MP0002138_abnormal_hepatobiliary_system | 0.83214455 |
| 71 | MP0002822_catalepsy | 0.81713595 |
| 72 | MP0003828_pulmonary_edema | 0.80632679 |
| 73 | MP0001348_abnormal_lacrimal_gland | 0.80544281 |
| 74 | MP0002998_abnormal_bone_remodeling | 0.80373930 |
| 75 | MP0003693_abnormal_embryo_hatching | 0.77883370 |
| 76 | MP0002132_abnormal_respiratory_system | 0.75150552 |
| 77 | MP0001986_abnormal_taste_sensitivity | 0.73962990 |
| 78 | MP0009765_abnormal_xenobiotic_induced | 0.68791152 |
| 79 | MP0005166_decreased_susceptibility_to | 0.68046131 |
| 80 | MP0004883_abnormal_blood_vessel | 0.67272818 |
| 81 | MP0004957_abnormal_blastocyst_morpholog | 0.64482550 |
| 82 | MP0009763_increased_sensitivity_to | 0.64057260 |
| 83 | MP0010094_abnormal_chromosome_stability | 0.62530957 |
| 84 | MP0003045_fibrosis | 0.61711388 |
| 85 | MP0000477_abnormal_intestine_morphology | 0.61399182 |
| 86 | MP0005381_digestive/alimentary_phenotyp | 0.59455495 |
| 87 | MP0000609_abnormal_liver_physiology | 0.59024755 |
| 88 | MP0003795_abnormal_bone_structure | 0.58128795 |
| 89 | MP0001243_abnormal_dermal_layer | 0.58039937 |
| 90 | MP0001663_abnormal_digestive_system | 0.56163457 |
| 91 | MP0000604_amyloidosis | 0.55837346 |
| 92 | MP0001216_abnormal_epidermal_layer | 0.52257151 |
| 93 | MP0009278_abnormal_bone_marrow | 0.51657374 |
| 94 | MP0000249_abnormal_blood_vessel | 0.51373624 |
| 95 | MP0000313_abnormal_cell_death | 0.51077578 |
| 96 | MP0008995_early_reproductive_senescence | 0.50966918 |
| 97 | MP0003453_abnormal_keratinocyte_physiol | 0.50713083 |
| 98 | MP0001881_abnormal_mammary_gland | 0.49587010 |
| 99 | MP0002928_abnormal_bile_duct | 0.49089743 |
| 100 | MP0009764_decreased_sensitivity_to | 0.48434021 |
| 101 | MP0001191_abnormal_skin_condition | 0.47174985 |
| 102 | MP0008007_abnormal_cellular_replicative | 0.46889009 |
| 103 | MP0000350_abnormal_cell_proliferation | 0.46539553 |
| 104 | MP0003221_abnormal_cardiomyocyte_apopto | 0.46035932 |
| 105 | MP0009115_abnormal_fat_cell | 0.45732893 |
| 106 | MP0001919_abnormal_reproductive_system | 0.45140019 |
| 107 | MP0001501_abnormal_sleep_pattern | 0.45064280 |
| 108 | MP0003111_abnormal_nucleus_morphology | 0.42096790 |
| 109 | MP0008874_decreased_physiological_sensi | 0.41812465 |
| 110 | MP0004185_abnormal_adipocyte_glucose | 0.41707982 |
| 111 | MP0003091_abnormal_cell_migration | 0.41668464 |
| 112 | MP0002136_abnormal_kidney_physiology | 0.41412417 |
| 113 | MP0009840_abnormal_foam_cell | 0.41267591 |
| 114 | MP0008058_abnormal_DNA_repair | 0.40464215 |
| 115 | MP0005535_abnormal_body_temperature | 0.39915994 |
| 116 | MP0002163_abnormal_gland_morphology | 0.39762852 |
| 117 | MP0001730_embryonic_growth_arrest | 0.39174227 |
| 118 | MP0008569_lethality_at_weaning | 0.38450554 |
| 119 | MP0000367_abnormal_coat/_hair | 0.38335477 |
| 120 | MP0005390_skeleton_phenotype | 0.38028868 |
| 121 | MP0003252_abnormal_bile_duct | 0.37687528 |
| 122 | MP0002693_abnormal_pancreas_physiology | 0.36654008 |
| 123 | MP0003183_abnormal_peptide_metabolism | 0.36292013 |
| 124 | MP0008873_increased_physiological_sensi | 0.36214838 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 8.20571838 |
| 2 | Abnormality of T cell number (HP:0011839) | 7.91462902 |
| 3 | Severe combined immunodeficiency (HP:0004430) | 6.27412210 |
| 4 | Combined immunodeficiency (HP:0005387) | 5.81074484 |
| 5 | Stomatitis (HP:0010280) | 5.77639590 |
| 6 | Abnormality of T cells (HP:0002843) | 5.76321040 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.58516372 |
| 8 | Recurrent fungal infections (HP:0002841) | 5.19349540 |
| 9 | Panhypogammaglobulinemia (HP:0003139) | 5.18073749 |
| 10 | Recurrent bronchitis (HP:0002837) | 5.05745443 |
| 11 | Recurrent cutaneous fungal infections (HP:0011370) | 4.83395425 |
| 12 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.83395425 |
| 13 | Recurrent viral infections (HP:0004429) | 4.58774394 |
| 14 | Chronic diarrhea (HP:0002028) | 4.57422376 |
| 15 | Nasal polyposis (HP:0100582) | 4.54837258 |
| 16 | Eczematoid dermatitis (HP:0000976) | 4.49810896 |
| 17 | Chronic otitis media (HP:0000389) | 4.49579563 |
| 18 | IgG deficiency (HP:0004315) | 4.49059853 |
| 19 | IgM deficiency (HP:0002850) | 4.44880147 |
| 20 | Autoimmune hemolytic anemia (HP:0001890) | 4.11405754 |
| 21 | Recurrent bacterial skin infections (HP:0005406) | 4.11112141 |
| 22 | Abnormality of eosinophils (HP:0001879) | 3.97301017 |
| 23 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.92016694 |
| 24 | Abnormality of the nasal mucosa (HP:0000433) | 3.74196683 |
| 25 | Eosinophilia (HP:0001880) | 3.72311369 |
| 26 | Increased IgM level (HP:0003496) | 3.70854365 |
| 27 | Joint swelling (HP:0001386) | 3.67413027 |
| 28 | Abnormality of B cell number (HP:0010975) | 3.66154065 |
| 29 | B lymphocytopenia (HP:0010976) | 3.66154065 |
| 30 | Abnormality of T cell physiology (HP:0011840) | 3.64472573 |
| 31 | Pustule (HP:0200039) | 3.63808877 |
| 32 | Abnormality of macrophages (HP:0004311) | 3.61007526 |
| 33 | Abnormality of the fingertips (HP:0001211) | 3.58104979 |
| 34 | Leukocytosis (HP:0001974) | 3.56884397 |
| 35 | Lymphopenia (HP:0001888) | 3.51670004 |
| 36 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.43672395 |
| 37 | Myositis (HP:0100614) | 3.42306698 |
| 38 | IgA deficiency (HP:0002720) | 3.26432230 |
| 39 | Granulocytopenia (HP:0001913) | 3.25772434 |
| 40 | Gastrointestinal infarctions (HP:0005244) | 3.17579167 |
| 41 | Thyroiditis (HP:0100646) | 3.17419648 |
| 42 | Hemoptysis (HP:0002105) | 3.15911807 |
| 43 | Prolonged bleeding time (HP:0003010) | 2.99842990 |
| 44 | Basal cell carcinoma (HP:0002671) | 2.99390210 |
| 45 | Hypochromic anemia (HP:0001931) | 2.96747498 |
| 46 | Cheilitis (HP:0100825) | 2.88244618 |
| 47 | Papilledema (HP:0001085) | 2.85666117 |
| 48 | Bronchitis (HP:0012387) | 2.83479504 |
| 49 | Pulmonary infiltrates (HP:0002113) | 2.80144037 |
| 50 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.75710494 |
| 51 | Lymphoma (HP:0002665) | 2.74403119 |
| 52 | Thrombocytosis (HP:0001894) | 2.73195484 |
| 53 | Vasculitis (HP:0002633) | 2.67334234 |
| 54 | Recurrent sinusitis (HP:0011108) | 2.66812359 |
| 55 | Hypoplasia of the thymus (HP:0000778) | 2.66295790 |
| 56 | Mediastinal lymphadenopathy (HP:0100721) | 2.65541359 |
| 57 | Autoimmune thrombocytopenia (HP:0001973) | 2.63883466 |
| 58 | Inflammation of the large intestine (HP:0002037) | 2.57461318 |
| 59 | Hypergammaglobulinemia (HP:0010702) | 2.56129383 |
| 60 | Increased IgE level (HP:0003212) | 2.53553853 |
| 61 | Gastrointestinal inflammation (HP:0004386) | 2.52651478 |
| 62 | Gingivitis (HP:0000230) | 2.51767905 |
| 63 | Retrobulbar optic neuritis (HP:0100654) | 2.51750671 |
| 64 | Optic neuritis (HP:0100653) | 2.51750671 |
| 65 | Slow saccadic eye movements (HP:0000514) | 2.48363796 |
| 66 | Meningitis (HP:0001287) | 2.47342778 |
| 67 | Colitis (HP:0002583) | 2.46062568 |
| 68 | Recurrent skin infections (HP:0001581) | 2.44789884 |
| 69 | Stomach cancer (HP:0012126) | 2.42074019 |
| 70 | Increased density of long bones (HP:0006392) | 2.39822128 |
| 71 | Hypochromic microcytic anemia (HP:0004840) | 2.38849633 |
| 72 | Spontaneous hematomas (HP:0007420) | 2.32057364 |
| 73 | Chest pain (HP:0100749) | 2.29168674 |
| 74 | Cellulitis (HP:0100658) | 2.28174676 |
| 75 | Chronic obstructive pulmonary disease (HP:0006510) | 2.23286468 |
| 76 | Obstructive lung disease (HP:0006536) | 2.23286468 |
| 77 | Chronic sinusitis (HP:0011109) | 2.23165117 |
| 78 | Urticaria (HP:0001025) | 2.22917384 |
| 79 | Arterial thrombosis (HP:0004420) | 2.19748702 |
| 80 | Ureteral stenosis (HP:0000071) | 2.17471300 |
| 81 | Encephalitis (HP:0002383) | 2.16762361 |
| 82 | Orchitis (HP:0100796) | 2.15605126 |
| 83 | Papilloma (HP:0012740) | 2.15141986 |
| 84 | Verrucae (HP:0200043) | 2.15141986 |
| 85 | Microcytic anemia (HP:0001935) | 2.14756150 |
| 86 | Hemiplegia (HP:0002301) | 2.14018413 |
| 87 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.13081992 |
| 88 | Acute hepatic failure (HP:0006554) | 2.08886269 |
| 89 | Recurrent otitis media (HP:0000403) | 2.08230822 |
| 90 | Anorexia (HP:0002039) | 2.08085709 |
| 91 | Amaurosis fugax (HP:0100576) | 2.05867040 |
| 92 | Persistence of primary teeth (HP:0006335) | 2.05270682 |
| 93 | Sepsis (HP:0100806) | 2.01513925 |
| 94 | Abnormality of the prostate (HP:0008775) | 1.99898852 |
| 95 | Hepatitis (HP:0012115) | 1.97322555 |
| 96 | Bronchiectasis (HP:0002110) | 1.96550685 |
| 97 | Abnormal platelet volume (HP:0011876) | 1.96212695 |
| 98 | Ureteral obstruction (HP:0006000) | 1.94859204 |
| 99 | Alveolar cell carcinoma (HP:0006519) | 1.94237500 |
| 100 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.94049581 |
| 101 | Episodic fever (HP:0001954) | 1.93791801 |
| 102 | Abnormality of the pleura (HP:0002103) | 1.91751543 |
| 103 | Seborrheic dermatitis (HP:0001051) | 1.91538553 |
| 104 | Epistaxis (HP:0000421) | 1.91278715 |
| 105 | Recurrent abscess formation (HP:0002722) | 1.90159694 |
| 106 | Pulmonary embolism (HP:0002204) | 1.89591092 |
| 107 | Poikiloderma (HP:0001029) | 1.88895102 |
| 108 | Emphysema (HP:0002097) | 1.86746991 |
| 109 | Abnormality of the endocardium (HP:0004306) | 1.86626018 |
| 110 | Keratoconjunctivitis sicca (HP:0001097) | 1.85708407 |
| 111 | Skin ulcer (HP:0200042) | 1.79167391 |
| 112 | Agammaglobulinemia (HP:0004432) | 1.78200389 |
| 113 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.75463569 |
| 114 | Entropion (HP:0000621) | 1.74971829 |
| 115 | Trigonocephaly (HP:0000243) | 1.74633145 |
| 116 | Periodontitis (HP:0000704) | 1.70271108 |
| 117 | Arthralgia (HP:0002829) | 1.70087056 |
| 118 | Gangrene (HP:0100758) | 1.69716225 |
| 119 | Keratoconjunctivitis (HP:0001096) | 1.65294434 |
| 120 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.63980325 |
| 121 | Gastrointestinal stroma tumor (HP:0100723) | 1.60016842 |
| 122 | Amyotrophic lateral sclerosis (HP:0007354) | 1.58541834 |
| 123 | Dislocated radial head (HP:0003083) | 1.58385771 |
| 124 | Gingival bleeding (HP:0000225) | 1.57873751 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 6.18315342 |
| 2 | MAP4K1 | 5.89644517 |
| 3 | JAK3 | 3.88106446 |
| 4 | ZAP70 | 3.51600346 |
| 5 | FGFR4 | 3.45684604 |
| 6 | ITK | 3.29969720 |
| 7 | PRPF4B | 3.25093564 |
| 8 | IKBKE | 2.77295525 |
| 9 | TYK2 | 2.53857310 |
| 10 | STK10 | 2.42337951 |
| 11 | NLK | 2.39456669 |
| 12 | RIPK4 | 2.36847651 |
| 13 | MAP3K14 | 2.22805213 |
| 14 | LCK | 2.08613919 |
| 15 | FGFR3 | 2.05707533 |
| 16 | TAOK3 | 1.99819162 |
| 17 | JAK1 | 1.94036298 |
| 18 | EEF2K | 1.90856417 |
| 19 | GRK6 | 1.83409067 |
| 20 | CAMKK2 | 1.79235373 |
| 21 | MAP3K10 | 1.69337368 |
| 22 | NME2 | 1.69297821 |
| 23 | CAMKK1 | 1.67104264 |
| 24 | TEC | 1.64497900 |
| 25 | KDR | 1.62048500 |
| 26 | CSK | 1.60675118 |
| 27 | TBK1 | 1.59896862 |
| 28 | MST4 | 1.35511993 |
| 29 | PRKCH | 1.33574536 |
| 30 | SYK | 1.32466305 |
| 31 | ERN1 | 1.28463151 |
| 32 | BTK | 1.23499039 |
| 33 | TESK2 | 1.23191252 |
| 34 | PRKCQ | 1.17812814 |
| 35 | TRIB3 | 1.13942340 |
| 36 | MAP3K13 | 1.10492726 |
| 37 | IKBKB | 1.09870613 |
| 38 | SMG1 | 1.08170520 |
| 39 | CDK12 | 1.05845657 |
| 40 | CHUK | 1.02299118 |
| 41 | * HCK | 1.02241841 |
| 42 | PKN2 | 1.02082480 |
| 43 | JAK2 | 1.00590025 |
| 44 | MAP3K7 | 1.00058813 |
| 45 | KIT | 0.99763133 |
| 46 | TLK1 | 0.97327129 |
| 47 | EPHA3 | 0.96347403 |
| 48 | TAOK1 | 0.96001886 |
| 49 | BLK | 0.94683711 |
| 50 | TSSK6 | 0.92253293 |
| 51 | MARK3 | 0.91988792 |
| 52 | LRRK2 | 0.89245453 |
| 53 | MAPK12 | 0.88490478 |
| 54 | RPS6KA4 | 0.87900775 |
| 55 | CLK1 | 0.85104512 |
| 56 | TYRO3 | 0.85092083 |
| 57 | EPHB1 | 0.83476729 |
| 58 | MAP3K1 | 0.83298360 |
| 59 | SIK2 | 0.82120735 |
| 60 | LYN | 0.70308317 |
| 61 | PIM1 | 0.69619867 |
| 62 | ALK | 0.69562759 |
| 63 | FGFR1 | 0.67964032 |
| 64 | FES | 0.67022302 |
| 65 | RET | 0.64285477 |
| 66 | PASK | 0.64111633 |
| 67 | MARK2 | 0.60851954 |
| 68 | SIK3 | 0.60183333 |
| 69 | TAOK2 | 0.58251531 |
| 70 | PDGFRB | 0.57993865 |
| 71 | TNK2 | 0.57776319 |
| 72 | MAP2K3 | 0.57555046 |
| 73 | CDK4 | 0.57368783 |
| 74 | BRD4 | 0.51725545 |
| 75 | TTN | 0.50913769 |
| 76 | INSR | 0.48338471 |
| 77 | MAP3K11 | 0.47874752 |
| 78 | PDK1 | 0.47452217 |
| 79 | IRAK4 | 0.47108503 |
| 80 | TGFBR1 | 0.44480925 |
| 81 | FYN | 0.42433884 |
| 82 | CAMK4 | 0.41701850 |
| 83 | TGFBR2 | 0.40817402 |
| 84 | FGR | 0.40578900 |
| 85 | IRAK1 | 0.39857528 |
| 86 | YES1 | 0.39393232 |
| 87 | MELK | 0.38669071 |
| 88 | MAP2K2 | 0.38402121 |
| 89 | STK11 | 0.37229340 |
| 90 | CDC42BPA | 0.37166633 |
| 91 | PIK3CG | 0.36844701 |
| 92 | BMPR2 | 0.36757246 |
| 93 | KSR2 | 0.35992801 |
| 94 | CSF1R | 0.35962745 |
| 95 | MAP3K8 | 0.34000788 |
| 96 | CDK19 | 0.32988768 |
| 97 | HIPK2 | 0.32338452 |
| 98 | RPS6KA5 | 0.32152779 |
| 99 | PRKD2 | 0.31900192 |
| 100 | SIK1 | 0.31518793 |
| 101 | MAPK11 | 0.30909449 |
| 102 | STK38 | 0.30655306 |
| 103 | NTRK2 | 0.30029868 |
| 104 | CDC7 | 0.29919065 |
| 105 | UHMK1 | 0.29783499 |
| 106 | NEK6 | 0.29275859 |
| 107 | EGFR | 0.29224863 |
| 108 | MAP3K4 | 0.29010407 |
| 109 | ROCK2 | 0.28596439 |
| 110 | PTK6 | 0.28196449 |
| 111 | DMPK | 0.27088078 |
| 112 | RPS6KL1 | 0.26644673 |
| 113 | RPS6KC1 | 0.26644673 |
| 114 | PDPK1 | 0.26138318 |
| 115 | MAP2K6 | 0.25294986 |
| 116 | MAPK3 | 0.24904538 |
| 117 | MAP3K12 | 0.24190628 |
| 118 | FGFR2 | 0.23658732 |
| 119 | STK4 | 0.22049547 |
| 120 | MAPK7 | 0.21688193 |
| 121 | MAPKAPK2 | 0.21427663 |
| 122 | CDK9 | 0.20994434 |
| 123 | RAF1 | 0.20102479 |
| 124 | CHEK1 | 0.19524207 |
| 125 | MAP3K3 | 0.19230064 |
| 126 | CDK6 | 0.17941438 |
| 127 | * IGF1R | 0.17224475 |
| 128 | MAPK4 | 0.16446338 |
| 129 | PIM2 | 0.16316194 |
| 130 | SRC | 0.15639983 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.98184318 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 4.37207602 |
| 3 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.56871088 |
| 4 | Measles_Homo sapiens_hsa05162 | 3.04366848 |
| 5 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.83729517 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.75383714 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.72032045 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.53174592 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.42836090 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.29360674 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.12891480 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.12174664 |
| 13 | Viral myocarditis_Homo sapiens_hsa05416 | 2.11275167 |
| 14 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.92902367 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.88029789 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.79773058 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.66529323 |
| 18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.59374042 |
| 19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.59117453 |
| 20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.57656926 |
| 21 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.53815066 |
| 22 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.44768877 |
| 23 | Hepatitis B_Homo sapiens_hsa05161 | 1.33825157 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.33630324 |
| 25 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.30354823 |
| 26 | HTLV-I infection_Homo sapiens_hsa05166 | 1.29650377 |
| 27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.26516222 |
| 28 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.20872316 |
| 29 | Shigellosis_Homo sapiens_hsa05131 | 1.19313579 |
| 30 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.19056317 |
| 31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.18776669 |
| 32 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.17880511 |
| 33 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.15927873 |
| 34 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.15215156 |
| 35 | Influenza A_Homo sapiens_hsa05164 | 1.11509184 |
| 36 | Asthma_Homo sapiens_hsa05310 | 1.10186459 |
| 37 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.08749622 |
| 38 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.06279534 |
| 39 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.06045410 |
| 40 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.00825400 |
| 41 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.00302154 |
| 42 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.98019879 |
| 43 | Legionellosis_Homo sapiens_hsa05134 | 0.96474516 |
| 44 | Spliceosome_Homo sapiens_hsa03040 | 0.96040839 |
| 45 | Colorectal cancer_Homo sapiens_hsa05210 | 0.94557599 |
| 46 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.94534976 |
| 47 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.94314753 |
| 48 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.93302825 |
| 49 | Apoptosis_Homo sapiens_hsa04210 | 0.85960765 |
| 50 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81024673 |
| 51 | Ribosome_Homo sapiens_hsa03010 | 0.80792858 |
| 52 | Hepatitis C_Homo sapiens_hsa05160 | 0.80408378 |
| 53 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.79393450 |
| 54 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.75993550 |
| 55 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.68622819 |
| 56 | Platelet activation_Homo sapiens_hsa04611 | 0.67374733 |
| 57 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.67214537 |
| 58 | Tuberculosis_Homo sapiens_hsa05152 | 0.64137233 |
| 59 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.62952079 |
| 60 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62719077 |
| 61 | RNA degradation_Homo sapiens_hsa03018 | 0.62518807 |
| 62 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.62197357 |
| 63 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.60341400 |
| 64 | Salmonella infection_Homo sapiens_hsa05132 | 0.60198089 |
| 65 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.60150065 |
| 66 | Malaria_Homo sapiens_hsa05144 | 0.60100163 |
| 67 | RNA transport_Homo sapiens_hsa03013 | 0.58461054 |
| 68 | DNA replication_Homo sapiens_hsa03030 | 0.57492344 |
| 69 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.56461617 |
| 70 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.56100318 |
| 71 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.56025287 |
| 72 | Thyroid cancer_Homo sapiens_hsa05216 | 0.55548777 |
| 73 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.55447435 |
| 74 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.54176897 |
| 75 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.52051279 |
| 76 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51682489 |
| 77 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.50745659 |
| 78 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.50518574 |
| 79 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.49408105 |
| 80 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.48045732 |
| 81 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.45900626 |
| 82 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.45712220 |
| 83 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.45632293 |
| 84 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.44815755 |
| 85 | Pertussis_Homo sapiens_hsa05133 | 0.44099590 |
| 86 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.43526044 |
| 87 | Mismatch repair_Homo sapiens_hsa03430 | 0.42599502 |
| 88 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.42486269 |
| 89 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41355760 |
| 90 | Other glycan degradation_Homo sapiens_hsa00511 | 0.41052274 |
| 91 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.40705429 |
| 92 | Endocytosis_Homo sapiens_hsa04144 | 0.40268377 |
| 93 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.40133997 |
| 94 | Base excision repair_Homo sapiens_hsa03410 | 0.39974527 |
| 95 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38568098 |
| 96 | Long-term potentiation_Homo sapiens_hsa04720 | 0.37701010 |
| 97 | Glioma_Homo sapiens_hsa05214 | 0.36733301 |
| 98 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.36640095 |
| 99 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36046818 |
| 100 | Prostate cancer_Homo sapiens_hsa05215 | 0.35687970 |
| 101 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.35427788 |
| 102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35237638 |
| 103 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.35217364 |
| 104 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.35095604 |
| 105 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.34945084 |
| 106 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.34276966 |
| 107 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.33101214 |
| 108 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32691067 |
| 109 | Endometrial cancer_Homo sapiens_hsa05213 | 0.31908137 |
| 110 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.31872664 |
| 111 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.30472376 |
| 112 | Insulin resistance_Homo sapiens_hsa04931 | 0.30266020 |
| 113 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.30153597 |
| 114 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.28219856 |
| 115 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.27872997 |
| 116 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.27181654 |
| 117 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.26284428 |
| 118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.25648408 |
| 119 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.25206191 |
| 120 | Adherens junction_Homo sapiens_hsa04520 | 0.25024515 |
| 121 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.23626376 |
| 122 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.23546084 |
| 123 | Pathways in cancer_Homo sapiens_hsa05200 | 0.23220495 |

